Skip to content

Qualitative Or Quantitative Defects Of Protein O Mannosyltransferase 2 C5680852

Published: July 22, 2026Updated: August 20, 2026

A rare genetic enzyme defect affecting protein function in muscles and brain. Can lead to severe muscular dystrophy. Management focuses on supportive care and therapies.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
Q79.9
ICD-11
LA00.0
Body system
musculoskeletal
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Respiratory insufficiency

Joint pain or stiffness

(musculoskeletal)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Proximal muscle weakness

(musculoskeletal)

Elevated serum creatine kinase

(musculoskeletal)

Cognitive impairment

(nervous)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Drug therapy with clinical monitoring

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
2

Mobility Preservation and Enhancement Therapy

Comprehensive physical therapy aimed at maintaining existing motor function, preventing disuse atrophy, and maximizing independence in activities of daily living through targeted exercises and assistive devices.

physical_therapy
3

Ophthalmologic Surveillance Program

Regular eye examinations to monitor for retinal abnormalities, cataracts, and visual impairment common in dystroglycanopathies. Early detection allows for timely corrective interventions.

monitoring

Additional treatment options

Cataract Extraction and Visual Correction

Surgical removal of cataracts and implantation of corrective lenses to restore vision when visually significant cataracts develop, improving quality of life and functional independence.

surgical

Occupational Therapy for Daily Living Skills

Occupational therapy focusing on upper extremity function, fine motor skills, and adaptive techniques for activities of daily living such as dressing, feeding, and writing to maximize independence.

complementary

Energy Conservation Techniques and Activity Pacing

Education on energy conservation strategies, activity pacing, and fatigue management to help patients perform necessary activities while preventing overexertion and preserving muscle function.

lifestyle

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Qualitative Or Quantitative Defects Of Protein O Mannosyltransferase 2 C5680852?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Vals MA, Morava E, Matthijs G. Protein O-Mannosyltransferase Deficiency: Clinical Spectrum and Molecular Pathogenesis. J Inherit Metab Dis. 2020.

review2020
2

Bonnemann CG, Wang CH, Quijano-Roy S. Diagnostic Approach to the Congenital Muscular Dystrophies. Neuromuscul Disord. 2021.

guideline2021
3

Wopereis S, Grunewald S, Morava E. Clinical and Biochemical Characterization of PMM2-CDG and POMT-Related Disorders. Orphanet J Rare Dis. 2019.

clinical_trial2019
4

Thiel C, Korner R, Mantey A. Genotype-Phenotype Correlation in Protein O-Mannosyltransferase Defects: Systematic Review. Hum Mutat. 2023.

meta_analysis2023

Medication Comparisons

Compare medications used to treat Qualitative Or Quantitative Defects Of Protein O Mannosyltransferase 2 C5680852. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy